UBS Group
LFST icon

UBS Group’s Lifestance Health LFST Stock Holding History

UBS Group’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.58M Sell
707,965
-19,917
-3% -$154K ﹤0.01% 3754
2026
Q1 		$4.64M Buy
727,882
+292,627
+67% +$2.04M ﹤0.01% 4157
2025
Q4 		$3.06M Sell
435,255
-966,193
-69% -$5.83M ﹤0.01% 4547
2025
Q3 		$7.71M Buy
1,401,448
+336,278
+32% +$1.65M ﹤0.01% 3577
2025
Q2 		$5.51M Buy
1,065,170
+605,861
+132% +$3.63M ﹤0.01% 3777
2025
Q1 		$3.06M Sell
459,309
-216,075
-32% -$1.64M ﹤0.01% 4298
2024
Q4 		$4.98M Buy
675,384
+584,816
+646% +$4.2M ﹤0.01% 3854
2024
Q3 		$634K Buy
90,568
+1,814
+2% +$10.9K ﹤0.01% 5042
2024
Q2 		$436K Sell
88,754
-16,636
-16% -$100K ﹤0.01% 5105
2024
Q1 		$650K Buy
105,390
+56,558
+116% +$381K ﹤0.01% 4985
2023
Q4 		$382K Buy
48,832
+41,366
+554% +$267K ﹤0.01% 5315
2023
Q3 		$51.3K Sell
7,466
-138,495
-95% -$1.12M ﹤0.01% 6278
2023
Q2 		$1.33M Buy
145,961
+117,020
+404% +$972K ﹤0.01% 3958
2023
Q1 		$215K Buy
28,941
+8,469
+41% +$47K ﹤0.01% 5331
2022
Q4 		$101K Buy
20,472
+9,972
+95% +$61.7K ﹤0.01% 6087
2022
Q3 		$70K Sell
10,500
-2,600
-20% -$18.1K ﹤0.01% 6033
2022
Q2 		$73K Sell
13,100
-29,190
-69% -$224K ﹤0.01% 5652
2022
Q1 		$427K Sell
42,290
-2,704
-6% -$23.7K ﹤0.01% 4796
2021
Q4 		$428K Buy
44,994
+34,325
+322% +$364K ﹤0.01% 5104
2021
Q3 		$155K Buy
10,669
+8,689
+439% +$167K ﹤0.01% 5517
2021
Q2 		$55K Buy
+1,980
New +$52.3K ﹤0.01% 6341

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

UBS Group's LFST Position: Q2 2026 in Review

UBS Group reduced its Lifestance Health (LFST) stake by 2.7% in Q2 2026, selling an estimated $154K and leaving 707,965 shares worth $7.58M. The position accounts for ﹤0.01% of the portfolio, ranked #3754.

UBS Group first reported a position in LFST in Q2 2021 and has held it in 21 quarters since. The position peaked at $7.71M in Q3 2025. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • UBS Group held 707,965 shares of Lifestance Health worth $7.58M as of Q2 2026.
  • UBS Group sold 19,917 Lifestance Health shares in Q2 2026, an estimated $154K.
  • Lifestance Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3754 holding.
  • UBS Group first reported a position in Lifestance Health in Q2 2021 and has held it in 21 quarters since.
  • UBS Group's Lifestance Health position peaked at $7.71M in Q3 2025.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.